ZOMETA® Prescribing Information – Summary Of European Product Characteristics
ZOMETA - Zoledronic AcidZOMETA - Zoledronic Acid Novartis Oncology
HomeZOMETA - International SiteZOMETA - US ResidentsZOMETA - Country Sites
ZOMETA - English ZOMETA - Deutsch ZOMETA - Espanol ZOMETA - Francais ZOMETA - Italiano
ZOMETA-Videos
Blue Arrow View videos on bone
metastases and the ZOMETA
mechanism of action

Learn more about the ZOMETA(zoledronic acid) mechanism of action

 
ZOMETA European Summary of Product Characteristics
Blue Arrow For non-U.S. Healthcare Professionals: Get information about ZOMETA and its product characteristics

Learn more about ZOMETA product characteristics
 
European Summary of Product Characteristics Handle with ZOMETA

 

The information below is provided in Portable Document Format (PDF). To view and print these documents, Adobe® Acrobat® Reader™ is required. If you need to download the free Adobe Acrobat Reader, click here.

ZOMETA® 4 mg powder and solvent for solution for infusion

ZOMETA 4 mg/5 ml concentrate for solution for infusion